IDEAYA Biosciences (IDYA) Depreciation & Amortization (CF) (2018 - 2026)

IDEAYA Biosciences has disclosed Depreciation & Amortization (CF) across 9 years of filings, most recently posting $688000.0 for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $688000.0, up 14.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 million (up 17.59% YoY), and the FY2025 annual result was $2.7 million, up 13.11% from the prior year.
• Depreciation & Amortization (CF) came in at $688000.0 for Q1 2026 at IDEAYA Biosciences, down from $721000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $721000.0 in Q4 2025 to a low of $464000.0 in Q1 2022.
• The 5-year median for Depreciation & Amortization (CF) is $616000.0 (2024), against an average of $608941.2.
• Across the five-year window, Depreciation & Amortization (CF) increased 26.72% in 2023 and decreased 9.84% in 2024, its largest moves.
• IDEAYA Biosciences' Depreciation & Amortization (CF) stood at $558000.0 in 2022, then advanced by 12.72% to $629000.0 in 2023, then fell by 9.06% to $572000.0 in 2024, then climbed by 26.05% to $721000.0 in 2025, then decreased by 4.58% to $688000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $688000.0 (Q1 2026), $721000.0 (Q4 2025), and $661000.0 (Q3 2025), per Business Quant data.